Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-03-22 @ 3:10 PM
Study NCT ID:
NCT01949220
Status:
COMPLETED
Last Update Posted:
2018-08-08
First Post:
2013-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Willebrand International Non-interventional Global Surveillance
Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies
Organization:
Study Overview
Official Title:
International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Collect information about WILLFACT or WILFACTIN in their real life clinical use and identify the therapeutic practices in an international environment.
Detailed Description:
Non-interventional, prospective, non comparative, international, multicentre study.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: